Intake of lactobacillus reuteri improves incretin and insulin secretion in Glucose-Tolerant humans: A proof of concept

Diabetes Care

Volumn 38, Issue 10, 2015, Pages 1827-1834

  Simon, Marie Christine ^a,b   Strassburger, Klaus ^a,b   Nowotny, Bettina ^a,b   Kolb, Hubert ^c   Nowotny, Peter ^a,b   Burkart, Volker ^a,b   Zivehe, Fariba ^a,b   Hwang, Jong Hee ^a,b   Stehle, Peter ^d   Pacini, Giovanni ^e   Hartmann, Bolette ^f   Holst, Jens J ^f   Mackenzie, Colin ^a   Bindels, Laure B ^g   Martinez, Ines ^g   Walter, Jens ^g,h   Henrich, Birgit ^g   Schloot, Nanette C ^a,b   Roden, Michael ^a,b,i  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^c West German Centre of Diabetes and Health   (Germany)

^d UNIVERSITY OF BONN   (Germany)

^e CNR   (Italy)

^f Capital Region   (Denmark)

^g UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^h UNIVERSITY OF ALBERTA   (Canada)

ⁱ Department of Orthopedic Surgery   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; ENDOTOXIN; GAMMA INTERFERON; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 2; GLUCOSE; INCRETIN; INSULIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLACEBO; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA; GLUCAGON; GLUCOSE BLOOD LEVEL; PROTEIN PRECURSOR;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BODY MASS; CALORIMETRY; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE RELEASE; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; FAT CONTENT; FEMALE; GLUCOSE INFUSION; GLUCOSE TOLERANCE; HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; HYPERINSULINEMIC-EUGLYCEMIC CLAMP TECHNIQUE; INSULIN RELEASE; INSULIN SENSITIVITY; LACTOBACILLUS REUTERI; LONGITUDINAL STUDY; MALE; NONHUMAN; NORMAL HUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PROSPECTIVE STUDY; PROTON NUCLEAR MAGNETIC RESONANCE; RANDOMIZED CONTROLLED TRIAL; STOMACH EMPTYING; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PHYSIOLOGY; PILOT STUDY; SECRETION (PROCESS);

ADULT; AGED; BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FEMALE; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-LIKE PEPTIDE 2; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HUMANS; INCRETINS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LACTOBACILLUS REUTERI; MALE; MIDDLE AGED; OBESITY; OXIDATIVE STRESS; PILOT PROJECTS; PROBIOTICS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS;

EID: 84962430714     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc14-2690     Document Type: Article

References (42)

1. Tabak AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimaki M, Witte DR. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: An analysis from the Whitehall II study. Lancet 2009;373: 2215-2221.
2. Vilsbøll T, Krarup T, Deacon CF, Madsbad S, Holst JJ. Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients. Diabetes 2001;50:609-613.
3. Kolb H, Mandrup-Poulsen T. The global diabetes epidemic as a consequence of lifestyleinduced low-grade inflammation. Diabetologia 2010;53:10-20.
4. Roden M. Mechanisms of Disease: hepatic steatosis in type 2 diabetesdpathogenesis and clinical relevance. Nat Clin Pract Endocrinol Metab 2006;2:335-348.
5. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesityassociated gut microbiome with increased capacity for energy harvest. Nature 2006;444: 1027-1031.
6. Larsen N, Vogensen FK, van den Berg FWJ, et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS ONE 2010;5:e9085.
7. Cani PD, Amar J, Iglesias MA, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007;56:1761-1772.
8. Cani PD, Possemiers S, Van de Wiele T, et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009;58:1091-1103.
9. Million M, Angelakis E, Paul M, Armougom F, Leibovici L, Raoult D. Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals. Microb Pathog 2012;53:100-108.
10. Silk DB, Davis A, Vulevic J, Tzortzis G, Gibson GR. Clinical trial: The effects of a transgalactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther 2009;29:508-518.
11. Cani PD, Lecourt E, Dewulf EM, et al. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr 2009;90:1236-1243.
12. Vrieze A, Van Nood E, Holleman F, et al. Transfer of intestinalmicrobiota fromlean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 2012; 143:913-916, e7.
13. Andreasen AS, Larsen N, Pedersen- Skovsgaard T, et al. Effects of Lactobacillus acidophilusNCFMon insulin sensitivity and the systemic inflammatory response in human subjects. Br J Nutr 2010;104:1831-1838.
14. Ejtahed HS, Mohtadi-Nia J, Homayouni-Rad A, Niafar M, Asghari-Jafarabadi M, Mofid V. Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition 2012;28:539-543.
15. Poutahidis T, Kleinewietfeld M, Smillie C, et al. Microbial reprogramming inhibits Western diet-associated obesity. PLoS ONE 2013;8: E68596.
16. Gøbel RJ, Larsen N, Jakobsen M, Mølgaard C, Michaelsen KF. Probiotics to adolescents with obesity: Effects on inflammation and metabolic syndrome. J Pediatr Gastroenterol Nutr 2012; 55:673-678.
17. Larsen N, Vogensen FK, Gøbel RJ, et al. Effect of Lactobacillus salivarius Ls-33 on fecal microbiota in obese adolescents. Clin Nutr 2013;32:935-940.
18. Qin J, Li Y, Cai Z, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012;490:55-60.
19. Karlsson FH, Tremaroli V, Nookaew I, et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 2013;498:99-103.
20. Jacobsen CN, Rosenfeldt Nielsen V, Hayford AE, et al. Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strains in humans. Appl Environ Microbiol 1999;65:4949-4956.
21. Segal KR, Van Loan M, Fitzgerald PI, Hodgdon JA, Van Itallie TB. Lean body mass estimation by bioelectrical impedance analysis: A four-site crossvalidation study. Am J Clin Nutr 1988;47:7-14.
22. Ziegler D, Schadewaldt P, Pour Mirza A, et al. [13C]octanoic acid breath test for noninvasive assessment of gastric emptying in diabetic patients: validation and relationship to gastric symptoms and cardiovascular autonomic function. Diabetologia 1996;39:823-830.
23. Pacini G, Mari A. Methods for clinical assessment of insulin sensitivity and beta-cell function. Best Pract Res Clin Endocrinol Metab 2003;17:305-322.
24. Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 2001;24:539-548.
25. Ahrén B, Pacini G. Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies. Eur J Endocrinol 2004;150:97-104.
26. Kautzky-Willer A, Krssak M, Winzer C, et al. Increased intramyocellular lipid concentration identifies impaired glucose metabolism in women with previous gestational diabetes. Diabetes 2003;52:244-251.
27. Nauck MA, El-Ouaghlidi A, Gabrys B, et al. Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes. Regul Pept 2004;122:209-217.
28. Nowotny B, Zahiragic L, Krog D, et al. Mechanisms underlying the onset of oral lipid-induced skeletal muscle insulin resistance in humans. Diabetes 2013;62:2240-2248.
29. Krssak M, Falk Petersen K, Dresner A, et al. Intramyocellular lipid concentrations are correlated with insulin sensitivity inhumans: A 1HNMR spectroscopy study. Diabetologia 1999;42:113-116.
30. Yang S, Lin S, Kelen GD, et al. Quantitative multiprobe PCR assay for simultaneous detection and identification to species level of bacterial pathogens. J Clin Microbiol 2002;40:3449-3454.
31. Byun R, Nadkarni MA, Chhour KL, Martin FE, Jacques NA, Hunter N. Quantitative analysis of diverse Lactobacillus species present in advanced dental caries. J Clin Microbiol 2004;42: 3128-3136.
32. Haarman M, Knol J. Quantitative real-time PCR analysis of fecal Lactobacillus species in infants receiving a prebiotic infant formula. Appl Environ Microbiol 2006;72:2359-2365.
33. Pfleger C, Mortensen HB, Hansen L, et al.; Hvidøre Study Group on Childhood Diabetes. Association of IL-1ra and adiponectin with C-peptide and remission in patients with type 1 diabetes. Diabetes 2008;57:929-937.
34. Habich C, Kempe K, van der Zee R, et al. Heat shock protein 60: specific binding of lipopolysaccharide. J Immunol 2005;174:1298-1305.
35. Ristow M, Zarse K, Oberbach A, et al. Antioxidants prevent health-promoting effects of physical exercise in humans. Proc Natl Acad Sci U S A 2009;106:8665-8670.
36. Orskov C, Rabenhøj L, Wettergren A, Kofod H, Holst JJ. Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans. Diabetes 1994;43:535-539.
37. Hartmann B, Johnsen AH, Orskov C, Adelhorst K, Thim L, Holst JJ. Structure, measurement, and secretion of human glucagonlike peptide-2. Peptides 2000;21:73-80.
38. Martinez I, Muller CE, Walter J. Long-term temporal analysis of the human fecal microbiota revealed a stable core of dominant bacterial species. PLoS ONE 2013;8:e69621.
39. Wichmann A, Allahyar A, Greiner TU, et al. Microbial modulation of energy availability in the colon regulates intestinal transit. Cell Host Microbe 2013;14:582-590.
40. Loguercio C, Federico A, Tuccillo C, et al. Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases. J Clin Gastroenterol 2005;39:540-543.
41. O'Connor LM, Lentjes MA, Luben RN, Khaw KT, Wareham NJ, Forouhi NG. Dietary dairy product intake and incident type 2 diabetes: A prospective study using dietary data from a 7-day food diary. Diabetologia 2014;57:909-917.
42. Mao Y, Nobaek S, Kasravi B, et al. The effects of Lactobacillus strains and oat fiber onmethotrexate- induced enterocolitis in rats. Gastroenterology 1996;111:334-344.